Novo Holdings A/S Q1 2018 Filing

Filed May 15, 2018

Portfolio Value

$797.4B

Holdings

17

Report Date

Q1 2018

Filing Type

13F-HR

All Holdings (17 positions)

#StockSharesValue% PortfolioType
1
INGNINOGEN INC
3,549,320$436.0B54.68%
2
XLRNACCELERON PHARMA INC
1,553,937$60.8B7.62%
3
MENLO THERAPEUTICS INC
1,361,313$51.2B6.42%
4
CRVSCORVUS PHARMACEUTICALS INC
4,420,516$51.0B6.39%
5
UNUM THERAPEUTICS INC
665,181$31.7B3.97%
6
AKBAAKEBIA THERAPEUTICS INC
3,100,000$29.5B3.70%
7
MRUSMERUS N V
1,410,417$26.1B3.28%
8
GKOSGLAUKOS CORP
565,165$17.4B2.19%
9
DERMIRA INC
1,993,746$15.9B2.00%
10
VRNAVERONA PHARMA PLC
740,740$14.8B1.86%
11
NABRIVA THERAPEUTICS PLC
2,924,822$14.7B1.84%
12
CRSPCRISPR THERAPEUTICS AG
223,317$10.2B1.28%
13
KIDSORTHOPEDIATRICS INC
624,591$9.4B1.18%
14
SPNEUSDSEASPINE HLDGS CORP
920,380$9.3B1.17%
15
RA PHARMACEUTICALS INC
1,465,838$7.8B0.98%
16
WRIGHT MED GROUP N V
4,622,032$6.3B0.79%
17
INVUITY INC
1,363,848$5.3B0.66%